FDA
The final article of the cycle provides additional clarifications regarding certain specific aspects associated with the use of electronic records in the context of clinical investigations.
FDA
The new article highlights special considerations for IT service providers, as well as the ones related to the use of digital health technologies.
FDA
The new article emphasizes specific focus areas the authority will pay attention to when evaluating compliance in the context of electronic record-keeping procedures.
FDA
The new article explains the approach to be followed in the context of retention and management of electronic records.
FDA
The article highlights the key points related to the use of electronic records based on the applicable legislation.
FDA
The final article of the cycle explains the specific metrics to be measured in the course of clinical studies in order to collect accurate and reliable information regarding the products in question.
RegDesk is recognized as a Regulatory Intelligence Representative Vendor! Learn more by reading the 2024 Gartner® Market Guide for Regulatory Intelligence Solutions.
Get the report
